Emerging pathogens are an increasing threat because most treatments for them are failing.
Read More about WBB Securities will be sponsoring a Demy-Colton Virtual Salon (webinar) on May 17, 2023For Immediate Release February 20, 2023 Cranford, NJ– Steve Brozak, DMH, President of WBB Securities today participated in a Biotech Showcase session titled, Capital Preservation: How to Preserve Capital and Retain Control of Your Research. It […]
Read More about Steve Brozak, President of WBB Securities Participated in the 2023 Biotech Showcase Session Titled, Capital Preservation: How to Preserve Capital and Retain Control of Your ResearchWBBRI assembled a panel of experts, including its own Director of Medical Research, Dr. Richard A. Marfuggi, to explain not only the physiologic processes of Covid/sepsis but also the critical importance of deployment and adoption of rapid diagnostics and targeted therapeutics
Read More about Meeting the Challenges of Sepsis in Severe Coronavirus Disease 2019: A Call to ArmsMonkeypox: The Next Healthcare Challenge – Understanding and Reckoning With It was published today as a Special Report by the Foreign Policy Association on the organization’s Web site.
Read More about Monkeypox: The Next Healthcare Challenge – Understanding and Reckoning With It – A Foreign Policy Association Special ReportWBB Securities acted as co-manager for a public offering, pre-funded warrants and warrants for SCYNEXIS, Inc.
Read More about WBB SECURITIES ACTS AS CO-MANAGER IN A $45 MILLION PUBLIC OFFERING, PRE-FUNDED WARRANTS AND WARRANTS FOR SCYNEXIS, INC.The Salon will feature three of the authors of a new, definitive report on the future of COVID, titled Getting to the Next Normal: A Roadmap for Living with COVID.
Read More about WBB Securities and WBB Research Institute Sponsors Demy-Colton’s Virtual Salon: Getting to the Next Normal: A Roadmap for Living with COVID